DTGCX
Price
$35.29
Change
-$0.86 (-2.38%)
Updated
Jul 24 closing price
Net Assets
518.04M
PRGTX
Price
$33.46
Change
-$0.86 (-2.51%)
Updated
Jul 24 closing price
Net Assets
7.84B
Interact to see
Advertisement

DTGCX vs PRGTX

DTGCX vs PRGTX Comparison Chart in %
View a ticker or compare two or three
VS
DTGCX vs. PRGTX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTGCX is a Hold and PRGTX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRGTX has more cash in the bank: 7.84B vs. DTGCX (518M). DTGCX (0.00) and PRGTX (0.00) have matching dividends . DTGCX was incepted earlier than PRGTX: DTGCX (27 years) vs PRGTX (26 years). DTGCX (1.97) is less costly to investors than PRGTX (0.93). PRGTX (34.60) and DTGCX (33.84) have comparable annual turnover. DTGCX has a lower initial minimum investment than PRGTX: DTGCX (1000) vs PRGTX (2500). PRGTX annual gain was more profitable for investors over the last year : 40.82 vs. DTGCX (4.51). PRGTX return over 5 years is better than : 4.33 vs. DTGCX (-18.42).
DTGCXPRGTXDTGCX / PRGTX
Total Expense Ratio1.970.93212%
Annual Report Gross Expense Ratio1.970.93212%
Fund Existence27 years26 years-
Gain YTD20.42026.02678%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets518M7.84B7%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.5140.8211%
Returns for 3 years51.07129.8139%
Returns for 5 years-18.424.33-425%
Returns for 10 years6.04134.814%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX22.810.16
+0.71%
Saratoga Health & Biotechnology A
FDTZX27.050.01
+0.04%
Fidelity Advisor Capital Development M
KGDIX39.05-0.16
-0.41%
DWS Global Small Cap Inst
SCMGX22.15-0.13
-0.58%
Sands Capital Global Growth Inst
TEMPX11.38-0.25
-2.15%
Nuveen Emerging Markets Eq Prem